About Us | Contact

Vrijendra Kumar Hoon Investigator

Southern Hills Hospital And Medical Center NPI1619073897
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$10,427.58
from 14 payments in the last 6 years

Total Cash or Cash Equivalent

$9,700.00
from 1 payments in the last 6 years

Total In-kind Items & Services

$727.58
from 13 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
11/02/2020 Research Cash or cash equivalent $9700.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
Clinical Trials Gov ID NCT03926130
Payment Record ID 728724961
09/20/2018 General (Non-Research) In-kind items and services Food and Beverage $14.44 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 607320769
11/29/2018 General (Non-Research) In-kind items and services Food and Beverage $16.80 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 607320765
01/16/2018 General (Non-Research) In-kind items and services Food and Beverage $1.88 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 607320763
01/12/2018 General (Non-Research) In-kind items and services Food and Beverage $1.94 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 607320759
04/09/2018 General (Non-Research) In-kind items and services Food and Beverage $12.26 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 607320753
07/20/2018 Research In-kind items and services $58.75 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368066
04/27/2018 Research In-kind items and services $50.04 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368061
04/27/2018 Research In-kind items and services $38.38 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368053
04/27/2018 Research In-kind items and services $20.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368050
04/27/2018 Research In-kind items and services $20.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368045
04/23/2018 Research In-kind items and services $468.96 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical Trials Gov ID NCT03285646
Payment Record ID 577368036
04/21/2017 General (Non-Research) In-kind items and services Food and Beverage $10.06 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 514374793
09/25/2017 General (Non-Research) In-kind items and services Food and Beverage $14.07 Details
Payment from Sunovion Pharmaceuticals Inc.
Payment Record ID 514146543
;